The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: Benefits versus risks - Authors' response [8]

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 1, 2008, Pages 227-228

  Hawkyard, Catherine V ^a   Koerner, Roland J ^a  

^a SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

Author keywords

Modular evolution; Non antimicrobial activities

Indexed keywords

BENZODIAZEPINE DERIVATIVE; ERYTHROMYCIN; INSULIN; METOCLOPRAMIDE; OPIATE DERIVATIVE; PROKINETIC AGENT;

ANTIBIOTIC RESISTANCE; COMBINATION CHEMOTHERAPY; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG TOLERABILITY; DRUG USE; ENTERIC FEEDING; GASTRIC DYSMOTILITY; HEALTH BELIEF; HUMAN; HYPERGLYCEMIA; HYPOALBUMINEMIA; INTENSIVE CARE; LETTER; LOW DRUG DOSE; MALNUTRITION; MONOTHERAPY; OUTCOME ASSESSMENT; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEDATION; STOMACH EMPTYING; STOMACH VOLUME; TREATMENT FAILURE;

EID: 37549044646     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm451     Document Type: Letter

References (5)

1. Hawkyard CV, Koerner RJ. The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: Benefits versus risks. J Antimicrob Chemother 2007; 59: 347-58.
2. Nguyen NQ, Chapman MJ, Fraser RJ et al. Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness. Crit Care Med 2007; 35: 483-9.
3. Nguyen NQ, Chapman M, Fraser RJ et al. Prokinetic therapy for feed intolerance in critical illness: One drug or two? Crit Care Med 2007; in press.
4. Deane A, Young R. Comment on: The use of erythromycin as a gastrointestinal prokinetic agent in adult critibal care: Benefits versus risks. J Antimicrob Chemother 2008; 61: 227.
5. Yavagal DR, Karnad DR, Oak JL. Metoclopramide for preventing pneumonia in critically ill patients receiving enterall tube feeding: A randomized controlled trial. Crit Care Med 2000; 28: 1408-11.